Nephrogenic Systemic Fibrosis: Histology and Gadolinium Detection

被引:16
|
作者
Thakral, Charu [1 ]
Abraham, Jerrold L. [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA
关键词
Nephrogenic systemic fibrosis; Histopathology; Gadolinium; Scanning electron microscopy; Energy dispersive x-ray spectroscopy; Mass spectrometry; Tissue analysis; Secondary ion mass spectrometry; LONG-TERM RETENTION; STAGE RENAL-DISEASE; CONTRAST AGENTS; DERMOPATHY; TISSUE; SKIN; QUANTIFICATION; INVOLVEMENT; MICROSCOPY; DEPOSITION;
D O I
10.1016/j.rcl.2009.06.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The association between gadolinium (Gd)-containing MR imaging contrast agents and the development of nephrogenic systemic fibrosis (INISF) is well recognized. The authors review the histopathologic features, methodology, and results Of analysis of tissues for Gd in NSF. Scanning electron microscopy/energy dispersive xray spectroscopy (SEM/EDS) provides sensitive detection of individual Gd-containing deposits in situ. Secondary ion mass spectroscopy has far greater sensitivity for detection of Gd than SEM/EDS and allows correlation at the cellular level. Inductively coupled plasma mass spectrometry is the recognized method for full quantitative analysis of Gd in tissues but requires destruction of the tissue and does not allow spatial correlation. In practice, the different analytic techniques provide complementary data and can be selected based on the information required.
引用
收藏
页码:841 / +
页数:15
相关论文
共 50 条
  • [21] Nephrogenic Systemic Fibrosis
    Kaewlai, Rathachai
    Abujudeh, Hani
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (01) : W17 - W23
  • [22] Nephrogenic systemic fibrosis
    Vosshenrich, R.
    Reimer, P.
    VASA-JOURNAL OF VASCULAR DISEASES, 2009, 38 (01): : 31 - 38
  • [23] Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update
    Idee, Jean-Marc
    Port, Marc
    Dencausse, Anne
    Lancelot, Eric
    Corot, Claire
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2009, 47 (05) : 855 - +
  • [24] Nephrogenic Systemic Fibrosis in the Podiatric Patient
    Freed, Lewis
    Hill, Josh
    Gooch, David
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2012, 102 (05) : 419 - 421
  • [25] Nephrogenic systemic fibrosis: concepts and perspectives
    de Souza Machado Igreja, Ana Carolina
    Mesquita, Kleyton de Carvalho
    Cowper, Shawn Edwin
    Carvalho Costa, Izelda Maria
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2012, 87 (04) : 597 - 607
  • [26] Nephrogenic systemic fibrosis - gadolinium disease?
    Economidou, D.
    Pateinakis, P.
    ARCHIVES OF HELLENIC MEDICINE, 2009, 26 (05): : 593 - 600
  • [27] The debate between gadolinium versus erythropoietin in a renal transplant patient with nephrogenic systemic fibrosis
    Hashemi, Pantea
    Sina, Bahram
    Rietkerk, William
    Safai, Bijan
    JOURNAL OF NEPHROLOGY, 2013, 26 (01) : 48 - 54
  • [28] Nephrogenic systemic fibrosis and the role of gadolinium contrast media
    van der Molen, A. J.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2008, 52 (04) : 339 - 350
  • [29] Gadolinium and Nephrogenic Systemic Fibrosis: Have We Overreacted?
    Penfield, Jeffrey G.
    Reilly, Robert F.
    SEMINARS IN DIALYSIS, 2011, 24 (05) : 480 - 486
  • [30] Gadolinium and nephrogenic systemic fibrosis: time to tighten practice
    Mendichovszky, Iosif A.
    Marks, Stephen D.
    Simcock, Clare M.
    Olsen, Oystein E.
    PEDIATRIC RADIOLOGY, 2008, 38 (05) : 489 - 496